“Global Veterinary Infusion Pumps Market to reach a market value of USD 381.9 Million by 2030 growing at a CAGR of 6.9%”
The Global Veterinary Infusion Pumps Market size is expected to reach $381.9 million by 2030, rising at a market growth of 6.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 2,668.2 hundred units, experiencing a growth of 6.0% (2019-2022).
The presence of modern veterinary clinics, specialty hospitals, and research institutions creates a conducive environment for the adoption of advanced medical devices, including infusion pumps. Therefore, the North America segment acquired $78,975.6 thousand in 2022. The United States has experienced a consistent increase in pet ownership rates. Dogs and cats, in particular, are popular companion animals, and the trend toward considering pets as family members has led to a higher demand for quality veterinary care. Veterinary practices in the United States offer comprehensive healthcare services for pets, mirroring the range of medical services available for humans.
As more people worldwide choose to keep pets, the demand for veterinary services and healthcare products has risen. Pets are family members, and pet owners are increasingly ready to invest in their animals' health and well-being. This tendency has resulted in a greater demand for specialized medical equipment to provide the best possible treatment for pets. The concept of companion animal healthcare has evolved, reflecting an increased focus on preventive and therapeutic care for pets. With this increased awareness and commitment to pet health, there is a corresponding demand for advanced medical devices that can provide accurate and controlled administration of medications, such as infusion pumps. Additionally, Advances in veterinary medicine often involve the development of new drugs or treatment protocols that require precise dosing. Infusion pumps offer a level of accuracy and control crucial in delivering medications to animals, especially in cases where precise dosing is essential for therapeutic efficacy or to avoid adverse effects. In such cases, continuous and controlled administration of medications and fluids is necessary, and infusion pumps provide a reliable mechanism for achieving this level of care. This is critical for maintaining the anesthesia level required for various surgical and diagnostic procedures while minimizing the risks associated with anesthesia. These aspects will pose lucrative growth prospects for the market.
However, developing countries may face budget constraints in allocating resources to build and maintain veterinary healthcare infrastructure. Limited financial resources may prioritize necessities over the acquisition of advanced medical equipment. The successful integration of advanced medical equipment requires trained professionals familiar with the technology. In regions with limited access to education and training programs for veterinary professionals, there may be a lack of skilled personnel capable of operating and maintaining infusion pumps. This can contribute to uncertainties regarding advanced veterinary equipment's quality, safety, and efficacy, hindering adoption and regulatory approval processes. These aspects can limit the growth of the market.
Further, global supply chains were disrupted due to the pandemic, disrupting the production and distribution of several medical products, including veterinary infusion pumps. Manufacturers faced difficulties procuring raw materials and components, potentially contributing to production and delivery delays. The pandemic influenced the operation of veterinary clinics and hospitals. Many veterinary practices had to adapt to social distancing measures, lockdowns, and changes in client behavior. Non-essential veterinary procedures were postponed or canceled, impacting the overall demand for certain veterinary medical devices. Economic challenges led some pet owners to reevaluate their insurance coverage or choose plans with different levels of coverage, potentially impacting the extent to which they can afford advanced medical treatments. Thus, the COVID-19 pandemic adversely affected the market.
Based on product type, the market is segmented into volumetric infusion pumps and syringe infusion pumps. The volumetric infusion pumps segment held the largest revenue share in the market in 2022. The increasing number of pet owners seeking comprehensive and advanced healthcare for their animals contributes to the demand for sophisticated medical devices. Volumetric infusion pumps are instrumental in delivering medications and fluids in a manner that ensures the well-being of pets. As a result, there will be increased demand in the segment.
On the basis of application, the market is divided into fluid therapy, anesthesia, pain management, nutrition, and others. In 2022, the anesthesia segment witnessed a substantial revenue share in the market. As veterinary medicine advances, a broader range of surgical and diagnostic procedures are being performed on animals. Many of these procedures require anesthesia to ensure the safety and comfort of the animal, contributing to the demand for infusion pumps specifically designed for anesthesia delivery. These aspects will lead to increased demand in the segment.
Based on route of administration, the market is divided into intravenous (IV), subcutaneous, epidural infusion, and others. The intravenous (IV) segment recorded the maximum revenue share in the market in 2022. Intravenous administration is crucial in critical care and emergencies in veterinary medicine. Infusion pumps used for IV delivery are vital in maintaining stable conditions for animals in intensive care units (ICUs), postoperative recovery, or cases requiring immediate medical attention. As a result, there will be an increased demand in the segment.
On the basis of animal type, the market is divided into companion animals and livestock animals. The livestock animals segment recorded a substantial revenue share in the market in 2022. Livestock animals are often raised in large-scale farming operations to meet the food industry's demands. Large herds or flocks require efficient and precise medication administration methods, nutrients, and other therapeutic agents, making valuable in such settings. These factors will lead to increased demand in the segment.
Based on end-use, the market is segmented into veterinary hospitals & clinics, home care, research & academic institutions, and others. The veterinary hospitals and clinics segment held the largest revenue share in the market in 2022. Veterinary hospitals and clinics are expanding their range of services to offer comprehensive healthcare solutions for animals. This includes specialized treatments, surgeries, and advanced therapies that may require infusion pumps for accurate and controlled drug delivery. Veterinary hospitals and clinics emphasize pain management and treating chronic conditions in animals. These factors will help in the expansion of the segment.
Free Valuable Insights: Global Veterinary Infusion Pumps Market size to reach USD 381.9 Million by 2030
By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. In 2022, the Europe segment acquired a considerable revenue share in the market. Europe has a high rate of pet ownership, and there is a growing trend of considering pets as integral family members. This trend will likely drive the demand for advanced veterinary care, including using infusion pumps for precise and controlled drug delivery. Owing to these factors, there will be increased demand in the segment
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 225.9 Million |
| Market size forecast in 2030 | USD 381.9 Million |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 6.9% from 2023 to 2030 |
| Quantitative Data | Volume in Hundred Units, Revenue in USD Million, and CAGR from 2019 to 2030 |
| Number of Pages | 484 |
| Number of Tables | 1090 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Product Type, Route of Administration, Animal Type, Application, End-Use, Region |
| Country scope |
|
| Companies Included | B. Braun Melsungen AG, Avante Health Solutions, Heska Corporation (Antech Diagnostics, Inc), Millpledge Veterinary Ltd., Leading Edge Veterinary Equipment, Grady Medical Systems, Eitan Medical Ltd., Digicare Biomedical Technology Inc., Burtons Medical Equipment, Shenzhen Mindray Animal Medical Technology Co., LTD. (Mindray Group) |
By Product Type (Volume, Hundred Units, USD Million, 2019-2030)
By Application (Volume, Hundred Units, USD Million, 2019-2030)
By Route of Administration (Volume, Hundred Units, USD Million, 2019-2030)
By Animal Type (Volume, Hundred Units, USD Million, 2019-2030)
By End-use (Volume, Hundred Units, USD Million, 2019-2030)
By Geography (Volume, Hundred Units, USD Million, 2019-2030)
The Market size is projected to reach USD $381.9 million by 2030.
Prevalence of chronic diseases in animals are driving the Market in coming years, however,Concerns about device safety and efficacy restraints the growth of the Market.
B. Braun Melsungen AG, Avante Health Solutions, Heska Corporation (Antech Diagnostics, Inc), Millpledge Veterinary Ltd., Leading Edge Veterinary Equipment, Grady Medical Systems, Eitan Medical Ltd., Digicare Biomedical Technology Inc., Burtons Medical Equipment, Shenzhen Mindray Animal Medical Technology Co., LTD. (Mindray Group)
In the year 2022, the market attained a volume of 2,668.2 hundred units, experiencing a growth of 6.0% (2019-2022).
The Fluid Therapy segment is generating the maximum revenue in the Market by Application in 2022; thereby, achieving a market value of $122.8 million by 2030.
The North America region dominated the Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $126.1 million by 2030.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 